Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Somatic Mutations Are Frequently Detected in CML Patients before Treatment-Free Remission (TFR) Attempt with Tyrosine Kinase Inhibitor (TKI) Discontinuation but with Uncertain Predictive Value for Tfr Failure

Blood (2022) 140 (Supplement 1): 6782–6783.

https://doi.org/10.1182/blood-2022-167927

Published: 2022

Journal Articles

Somatic Mutations in Myeloid Transcription Factors and in Activated Signaling Pathway, but Not in Epigenetic Modifier Pathway, Predict the Risk of Treatment Failure and Progression to Advanced Phase in Chronic Myeloid Leukemia

Taehyung Kim, Daniela Žácková, Ivana Ježíšková, Anežka Kvetková, Tomáš Jurček, Young Seok Yoo, Hyewon Lee, Kyoung Ha Kim, Myung Hee Chang, Seong Yoon Yi, Jessie J.F. Medeiros, Sagi Abelson, Dennis Kim

Blood (2022) 140 (Supplement 1): 812–814.

https://doi.org/10.1182/blood-2022-162676

Published: 2022

Journal Articles

The Prognostic Impact of HMGCLL1 Gene Variant on Treatment Outcomes in Chronic Myeloid Leukemia (CML) Patients: Adverse Impact on the Response, Failure, and Progression with Imatinib Which Can be Abrogated By the Use of 2 nd Generation Tyrosine Kinase Inhibitor (TKI) Upfront Therapy

Blood (2022) 140 (Supplement 1): 6774–6775.

https://doi.org/10.1182/blood-2022-168228

Published: 2022

Journal Articles

Single-Cell Proteogenomic Sequencing Allows Early Detection of Relapse Clone with CN-LOH at FLT3 -ITD Locus from Initial Diagnosis in AML

Taehyung Kim, Hyewon Lee, Jose-Mario Capo-Chichi, Myung Hee Chang, Young Seok Yoo, Gurbaksh Basi, Troy Ketela, Adam C. Smith, Anne Tierens, Mark D. Minden, Zhaolei Zhang, Dennis Dong Hwan Kim

Blood (2021) 138 (Supplement 1): 3428.

https://doi.org/10.1182/blood-2021-146572

Published: 2021

Journal Articles

Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS)

Sung-Eun Lee, MD, Joon Seong Park, MD, Hyeoung-Joon Kim, MD PhD, Sung-Hyun Kim, MD PhD, Dae Young Zang, MD PhD, Sukjoong Oh, MD PhD, Young Rok Do, PhDMD, Yunsuk Choi, MD, Jae-Yong Kwak, MD PhD, Jeong-A Kim, MD PhD, Kyoo Hyung Lee, MD PhD, Yeung-Chul Mun, MD, Won Sik Lee, MD PhD, Myung Hee Chang, MD, Jinny Park, MD PhD, Jihyun Kwon, MD, Dong-Wook Kim

Blood (2019) 134 (Supplement_1): 1643.

https://doi.org/10.1182/blood-2019-126376

Published: 2019

Journal Articles

High Incidence of Hepatitis B Viral Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Jieun Uhm, MD PhD, Sung-Hyun Kim, MD PhD, Sukjoong Oh, MD PhD, Dae Young Zang, MD PhD, Young Rok Do, PhD MD, Won Sik Lee, MD PhD, Myung Hee Chang, MD, Sung-Eun Lee, MD PhD, Dong-Wook Kim, MD PhD

Blood (2018) 132 (Supplement 1): 3010.

https://doi.org/10.1182/blood-2018-99-117543

Published: 2018

Journal Articles

Clinical Outcomes in Patients with Diffuse Large B Cell Lymphoma with Partial Responses to First-Line R-CHOP Chemotherapy: Prognostic Value of Secondary IPI Scores and FDG-PET

Hyewon Lee, MD, Yu Ri Kim, Soo-Jeong Kim, MD, Yong Park, MD PhD, Hyeon-Seok Eom, Sung Yong Oh, MD, Hyo Jung Kim, Hye Jin Kang, Won-Sik Lee, Joon Ho Moon, MD, PhD, Young-Woong Won, MD PhD, Myung Hee Chang, Hye In Park, Jin Seok Kim, MD PhD

Blood (2016) 128 (22): 4205.

https://doi.org/10.1182/blood.V128.22.4205.4205

Published: 2016

Journal Articles

Clinical Outcomes of R-CHOP Chemotherapy Alone Compared with R-CHOP Plus Radiotherapy in Patients with Localized, Non-Bulky Diffuse Large B-Cell Lymphoma

Blood (2014) 124 (21): 4421.

https://doi.org/10.1182/blood.V124.21.4421.4421

Published: 2014

Journal Articles

Side Population of Multiple Myeloma and Multiple Myeloma Stem Cell

Kyoung Ha Kim, Hee-Jeong Cheong, Sook-Ja Kim, Se Hyung Kim, Jina Yoon, Han Jo Kim, Hyun Jung Kim, Sang-Cheol Lee, Sang Byung Bae, Chan-Kyu Kim, Namsu Lee, Kyu Taeg Lee, Sung Kyu Park, Dae Sik Hong, Jong-Ho Won, MD, Hyun Jung Jun, Myung Hee Chang

Blood (2014) 124 (21): 5786.

https://doi.org/10.1182/blood.V124.21.5786.5786

Published: 2014

Journal Articles

Results From The Korean Imatinib Discontinuation Study (KIDS): Updated Data With 14-Month Median Follow Up

Blood (2013) 122 (21): 4003.

https://doi.org/10.1182/blood.V122.21.4003.4003

Published: 2013

Journal Articles

Prospective Cohort Study with Risk-Adapted Central Nervous System (CNS) Evaluation in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Analysis of Incidence and Risk Factors for Secondary CNS Involvement.

Blood (2012) 120 (21): 2683.

https://doi.org/10.1182/blood.V120.21.2683.2683

Published: 2012

Journal Articles

Therapeutic Comparision of Surgical Resection Followed by R-CHOP and R-CHOP Alone for Primary Localized Intestinal Diffuse Large B Cell Lymphoma

Ho Sup Lee, Lee Chun Park, MD, Eun Mi Lee, Seong Hoon Shin, MD, Byeong Jin Ye, MD, Sung Yong Oh, Moo-kon Song, Sang Min Lee, MD, Won-Sik Lee, MD, Byung Woog Kang, Myung Hee Chang, Seok-Goo Cho, Seung-Ah Yahng, Sung-Soo Yoon, MD, PhD, Ji-Hyun Kwon, Yang Soo Kim

Blood (2011) 118 (21): 1627.

https://doi.org/10.1182/blood.V118.21.1627.1627

Published: 2011

Journal Articles

Dasatinib for Chronic Phase Chronic Myeloid Leukemia After Failure of Imatinib In Korean Patients.

Ha Yeon Lee, Myung-Hee Chang, Chul Won Jung, Dong Hwan (Dennis) Kim, Won Seog Kim, Seok Jin Kim, MD, PhD, Kihyun Kim, MD, Jun Ho Jang, Sung-Soo Yoon, Kyoo-Hyung Lee, M.D., PhD., Hyeoung Joon Kim, MD, PhD, Joo-Seop Chung, MD, Sang Kyun Sohn

Blood (2010) 116 (21): 4494.

https://doi.org/10.1182/blood.V116.21.4494.4494

Published: 2010

Journal Articles

Genetic Variants in the Candidate Genes of the Apoptosis Pathway and Susceptibility to Chronic Myeloid Leukemia

Dong Hwan Kim, MD, PhD, Kyoung Ha Kim, M.D., Myung Hee Chang, M.D., Wei Xu, PhD, Clement Ma, MSc, Xiangdong Liu, Ph.D., Katherine Siminovitch, M.D./Ph.D., Hans A. Messner, M.D./Ph.D, Jeffrey H. Lipton, MD, PhD

Blood (2008) 112 (11): 4223.

https://doi.org/10.1182/blood.V112.11.4223.4223

Published: 2008

Journal Articles

BCL2 Gene Polymorphism Could Predict the Treatment Outcomes in Patients with De Novo Acute Myeloid Leukemia

Kyoung Ha Kim, M.D., Dong Hwan Kim, MD, PhD, Su Jin Lee, M.D., Joon Ho Moon, M.D., Myung Hee Chang, M.D., Myung Hoon Lee, PhD, Chul Won Jung, M.D./Ph.D., Sang Kyun Sohn, M.D./Ph.D.

Blood (2008) 112 (11): 3973.

https://doi.org/10.1182/blood.V112.11.3973.3973

Published: 2008

Journal Articles

Neutrophil Counts Could Predict the Response to Immunosuppressive Treatment with Antithymocyte Globulin and Cyclosporine in the Patients with Severe Aplastic Anemia

Myung Hee Chang, M.D., Dong Hwan Kim, MD, PhD, Kyoung Ha Kim, M.D., Hee Kyung Ahn, M.D., Su Jin Lee, M.D., Jun Ho Jang, M.D./Ph.D., Kihyun Kim, M.D./Ph.D., Chul Won Jung, M.D./Ph.D.

Blood (2008) 112 (11): 4109.

https://doi.org/10.1182/blood.V112.11.4109.4109

Published: 2008

Journal Articles

Treatment Outcome and Prognostic Factors in Patients with Precursor B and T Lymphoblastic Lymphoma

Myung Hee Chang, Seok Jin Kim, MD, PhD, Won Seog Kim, Chul Won Choi, MD, PhD, Cheolwon Suh, Sung Hyun Kim, MD, PhD, Deok-Hwan Yang, Jong-Ho Won, Soon Il Lee

Blood (2008) 112 (11): 3601.

https://doi.org/10.1182/blood.V112.11.3601.3601

Published: 2008

NARROW

Somatic Mutations Are Frequently Detected in CML Patients before Treatment-Free Remission (TFR) Attempt with Tyrosine Kinase Inhibitor (TKI) Discontinuation but with Uncertain Predictive Value for Tfr Failure

Somatic Mutations in Myeloid Transcription Factors and in Activated Signaling Pathway, but Not in Epigenetic Modifier Pathway, Predict the Risk of Treatment Failure and Progression to Advanced Phase in Chronic Myeloid Leukemia

The Prognostic Impact of HMGCLL1 Gene Variant on Treatment Outcomes in Chronic Myeloid Leukemia (CML) Patients: Adverse Impact on the Response, Failure, and Progression with Imatinib Which Can be Abrogated By the Use of 2 nd Generation Tyrosine Kinase Inhibitor (TKI) Upfront Therapy

Single-Cell Proteogenomic Sequencing Allows Early Detection of Relapse Clone with CN-LOH at FLT3 -ITD Locus from Initial Diagnosis in AML

Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS)

High Incidence of Hepatitis B Viral Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Clinical Outcomes in Patients with Diffuse Large B Cell Lymphoma with Partial Responses to First-Line R-CHOP Chemotherapy: Prognostic Value of Secondary IPI Scores and FDG-PET

Comparison of Molecular Kinetics after the First and Second Imatinib Discontinuation: Results from the KID Study

Clinical Outcomes of R-CHOP Chemotherapy Alone Compared with R-CHOP Plus Radiotherapy in Patients with Localized, Non-Bulky Diffuse Large B-Cell Lymphoma

Side Population of Multiple Myeloma and Multiple Myeloma Stem Cell

Results From The Korean Imatinib Discontinuation Study (KIDS): Updated Data With 14-Month Median Follow Up

Prospective Cohort Study with Risk-Adapted Central Nervous System (CNS) Evaluation in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Analysis of Incidence and Risk Factors for Secondary CNS Involvement.

Therapeutic Comparision of Surgical Resection Followed by R-CHOP and R-CHOP Alone for Primary Localized Intestinal Diffuse Large B Cell Lymphoma

Dasatinib for Chronic Phase Chronic Myeloid Leukemia After Failure of Imatinib In Korean Patients.

Genetic Variants in the Candidate Genes of the Apoptosis Pathway and Susceptibility to Chronic Myeloid Leukemia

BCL2 Gene Polymorphism Could Predict the Treatment Outcomes in Patients with De Novo Acute Myeloid Leukemia

Neutrophil Counts Could Predict the Response to Immunosuppressive Treatment with Antithymocyte Globulin and Cyclosporine in the Patients with Severe Aplastic Anemia

Treatment Outcome and Prognostic Factors in Patients with Precursor B and T Lymphoblastic Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only